Data443 Risk Mitigation, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
DATA443 Risk Mitigation, Inc. reported a reduced net loss for the nine months ended September 30, 2025, but continues to face substantial doubt about its ability to continue as a going concern.
OTC.Pink
DATA443 Risk Mitigation, Inc. reported a significant reduction in net loss for Q2 2025, driven by cost of revenue efficiencies, despite a slight decrease in overall revenue.
OTC.Pink
DATA443 Risk Mitigation, Inc. reported a reduced net loss for Q1 2025, but faces substantial doubt about its ability to continue as a going concern due to worsening liquidity, a growing accumulated deficit, and significant shareholder dilution from debt conversions.
OTC.Pink
Data443 Risk Mitigation, Inc. reports a 65% increase in revenue for the third quarter of 2024 compared to the same period last year, alongside a reduced net loss.
OTC.Pink
Data443 Risk Mitigation reports increased revenue year-over-year, driven by the Cyren acquisition, but also a significant increase in net loss due to higher costs and interest expenses.
OTC.Pink
Data443 Risk Mitigation, Inc. reports a revenue increase for Q1 2024, driven by the Cyren acquisition, but faces a larger net loss due to higher costs and interest expenses.